Tenderwize
Wróć do wyszukiwania

Open House Originale Propranolol Oral Solution

Techniker Krankenkasse·Hamburg, Germany·Deadline Dec 30, 2027 · 492 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-33 - Propranolol (Darreichungsform: Lösung zum Einnehmen)

62/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

62 / 100

Złożoność

58 / 100

Czynniki ryzyka

The notice says offers/contracts cannot be submitted via the procurement portal; they must be sent by email with qualif...

Only pharmaceutical undertakings for the relevant product, with the required seat and authorization status, may partici...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Dec 2027
  • Supply of pharmaceutical products, specifically Propranolol in oral solution form.
  • Open-house contract model with uniform conditions and no individual negotiations.
Pokaż pełne podsumowanie

This is an open-house style supply arrangement for Propranolol oral solution in Germany, led by Techniker Krankenkasse with hkk and HEK as participating buyers. The notice states that all suitable pharmaceutical companies may join during the contract period under uniform conditions, with no exclusivity and no individual negotiations. No contract value is provided. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and the participation documents are only available electronically via the buyer portal. The extracted documents were analyzed, but the actual participation/contract documents themselves were not provided.

Ryzyka

The notice says offers/contracts cannot be submitted via the procurement portal; they must be sent by email with qualif...

Only pharmaceutical undertakings for the relevant product, with the required seat and authorization status, may partici...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of § 4(18) AMG for the relevant product.
  • Applicant must have its seat in Germany, another EU Member State, or an EEA state.
  • Applicant must hold a valid marketing authorization for the relevant medicinal product, or otherwise be entitled to place it on the market in its own name.

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (1)

LOT-0001

Open House Originale Propranolol Oral Solution

Supply arrangement for Propranolol in oral solution form. The lot is described as a nationwide open-house contract under § 130c SGB V, with uniform terms for all eligible pharmaceutical companies. The extracted notice text indicates that participation documents are only provided to companies that market, or can credibly demonstrate they will market, the relevant medicinal product during the contract period.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Dec 2025 - Dec 2027

Kategoria

Pharmaceutical products

Termin

Deadline Dec 30, 2027

Szczegóły zamówienia

Data publikacji
19 Oct 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
689646-2025

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3